Kite Pharmaceuticals, Inc.
Sep 3, 2015

Kite Pharma to Participate in Upcoming Investor Conferences in September 2015

SANTA MONICA, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that the management team will participate in two upcoming investor conferences this month:

Date: Thursday, September 10, 2015
Time: 11:00am Eastern Time
Location: New York, NY

Date: Thursday, September 17, 2015
Time: 1:30pm Eastern Time
Location: New York, NY

The Company's corporate overview to be presented at the Morgan Stanley Global Healthcare Conference will be available through the Calendar of Events section of the Company's website at

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit

CONTACT: Kite Pharma

         Cynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer



         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns

         Burns McClellan